BCA
EDVA

Berman Capital Advisors’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Berman Capital Advisors’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$15K Buy
+49
New +$22.1K ﹤0.01% 1073

Other funds holding EDVA

PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Berman Capital Advisors's EDVA Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Endovia Health Sciences, Inc. (EDVA) in Q3 2021: 49 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #1073 among its holdings.

13 funds tracked by Wall St. Rank hold EDVA as of Q3 2021.

  • Berman Capital Advisors held 49 shares of Endovia Health Sciences, Inc. worth $15K as of Q3 2021.
  • Endovia Health Sciences, Inc. was a new Berman Capital Advisors position in Q3 2021.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1073 holding.
  • 13 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.